| A5 | Proteomic evidence of vesatolimod-induced enhancement of 'cross-talk' between innate and adaptive immune cells in HIV controllers on ART | On-demand oral abstract session | Innate immunity |
| B60 | Proof of principle oral dissolvable strip formulation for pediatric ARV prophylaxis | E-poster | Drug formulations for infants and children |
| D9 | Promotion of mutual disclosure of HIV serostatus among men who have sex with men in China: a social exchange model | E-poster | Feasibility and acceptability of emerging HIV prevention strategies |
| B78 | Progression risk in people with HIV and COVID-19: predictive performance of current risk scores | E-poster | COVID-19 morbidity and mortality in PLWH |
| D50 | Progress towards the UNAIDS 95'95'95 targets among pregnant women in South Africa: results from the 2017 and 2019 national antenatal HIV sentinel surveys | E-poster | Monitoring and evaluation of HIV cascade |
| B13 | Progress towards HCV elimination among HIV-positive men who have sex with men in Germany: a modeling analysis | E-poster | Viral hepatitis C |
| C1 | Progress and setbacks in HIV/AIDS mortality in Mexico from 1990 to 2019 | E-poster | Epidemiology of HIV in the general population |
| D48 | Profiling the case characteristics of individuals with recent HIV infection among those newly confirmed HIV-positive in Vietnam | E-poster | Monitoring and evaluation of testing |
| C28 | Prioritizing the evaluation of HIV prevention interventions in pregnancy: Interim results from a randomized, open-label safety trial of dapivirine vaginal ring and oral tenofovir disoproxil fumarate/emtricitabine use in late pregnancy | E-poster | Microbicides (including vaginal and rectal microbicides) |
| B15 | Prevlence of trichomonas vaginalis and mycoplasma genitalium among women randomized to DMPA-IM, copper IUD and levonorgestrel implant in the echo trial | E-poster | Syphilis and other sexually transmitted infections |